Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Rajer Mirjana) .

1 - 10 / 23
First pagePrevious page123Next pageLast page
1.
Malignant spinal cord compression
Mirjana Rajer, Viljem Kovač, 2008, review article

Abstract: Malignant spinal cord compression (MSCC) is a common and debilitating neurological complication of cancer. Because of the rapid progression of the neurological dysfunction, it is considered a medical emergency that demands a prompt diagnosis and treatment. Almost all of the MSCC are caused by an epidural compression from a tumour or a bony fragment from the collapsed vertebra affected by the metastasis. The most common of the tumours that metastasize to the spinal cord are breast and lung cancer, followed by lymphoma, myeloma, prostate cancer and sarcoma. Conclusions. The most common symptom of MSCC is pain, followed by muscular weakness and autonomic dysfunction. MRI provides the best information regarding MSCC, so all patientsshould have a MRI as soon as possible. If the MRI is contraindicated, patients should have the CT scan done. All patients with newly diagnosed MSCC should receive corticosteroids immediately, even before the definitive diagnosis is made. Other treatment options are surgery with postoperative radiotherapy, radiotherapy only, specific medical therapies according to the tumour type and symptomatic therapy, (mainly opiates). The decision of treatment modalities should be made according to the NOMS (neurological, oncological, mechanical and systemic) principles. In spite of the advances, the treatment is still palliative and many patients with MSCC have a poor prognosis and a short survival.
Published in DiRROS: 07.03.2024; Views: 74; Downloads: 17
.pdf Full text (152,89 KB)

2.
Kidney cancer
Mirjana Rajer, 2007, professional article

Published in DiRROS: 20.02.2024; Views: 94; Downloads: 24
.pdf Full text (213,38 KB)

3.
Basic Clinical Radiobiology Course Ljubljana (Slovenia), 21.-25. May 2006 : view from local participant
Mirjana Rajer, 2007, other component parts

Published in DiRROS: 20.02.2024; Views: 90; Downloads: 26
.pdf Full text (66,97 KB)

4.
Locoregional control and survival after breast conserving therapy
Mirjana Rajer, Elga Majdič, 2006, original scientific article

Published in DiRROS: 15.02.2024; Views: 82; Downloads: 24
.pdf Full text (631,72 KB)

5.
Quantitative analysis of fine needle aspiration biopsy samples
Mirjana Rajer, Marko Kmet, 2005, original scientific article

Abstract: The fine needle aspiration biopsy (FNAB) is one of the methods used in tumour evaluation. Since a certain number of tumour cells are needed for a complete diagnostic algorithem, we wanted to test how many cells remain in the needle and syringe after routine stains have been made and which factors influence this number. The remaining cells are used in ancillary diagnostic procedures. Material and methods. One hundred fifty two FNAB samples of tumours of the breast, thyroid and lymph nodes were included in our study. We counted the cells which were left in the needle and the syringe after the standard smears had been made. Buerker-Tuerks chamber was used for this purpose. Results. The number of cells depended on the organ from which the cells had been aspirated,on the type of tumour and, in the case of breast cancer, also on thelevel of experience of the FNAB performer. The percentage of samples with too few cells for all modern diagnostic methods (<5x105) is lowest in FNAB of lymph nodes (4.9%), followed by breast (16.7%) and thyroid (18%). Conclusions.We concluded that FNAB in the majority of cases grants a sufficient number of cells for the standard microscopic evaluation and also ancillary diagnostic procedures.
Published in DiRROS: 14.02.2024; Views: 100; Downloads: 23
.pdf Full text (104,56 KB)

6.
Mnenje za spremljanje bolnikov po preboleli covidni pljučnici
Matjaž Turel, Natalija Edelbaher, Matjaž Fležar, Matevž Harlander, Peter Kecelj, Izidor Kern, Majda Kočar, Peter Kopač, Mitja Košnik, Robert Marčun, Igor Požek, Mirjana Rajer, Irena Šarc, Jurij Šorli, Dušanka Vidovič, Katarina Osolnik, 2021, original scientific article

Abstract: Pljučnica je najpogostejši vzrok za težji potek okužbe z virusom SARS-CoV-2 in s hospitalizacijo. Potek covidne pljučnice je lahko različen; infiltrati, vidni na rentgenski sliki, se lahko resorbirajo spontano, včasih pa je potrebno zdravljenje s sistem-skimi glukokortikoidi. Ob odpustu iz bolnišnice zdravljenje običajno še ni končano, zato je Združenje pulmologov Slovenije v želji po enotnem obravnavanju bolnikov s covidno pljučnico izdelalo mnenje za obravnavo in sledenje bolnikov po od-pustu iz bolnišnice. Zavedamo se, da ob novi bolezni ne gre za dokončno priporočilo, saj bodo nova spoznanja o covidni pljučnici zanesljivo zahtevala obnavljanje priporočil.
Keywords: covid-19, mnenja, pljučnica, pulmologija, sistemski glukokortikoidi, covidna pljučnica
Published in DiRROS: 15.12.2021; Views: 1060; Downloads: 188
URL Link to file

7.
Epidemiologija in etiologija pljučnega raka
Mirjana Rajer, 2015, published professional conference contribution (invited lecture)

Keywords: pljučni rak, epidemiologija, etiologija
Published in DiRROS: 08.05.2020; Views: 1485; Downloads: 429
.pdf Full text (323,91 KB)

8.
Prvi šoli pljučnega raka na pot
Mirjana Rajer, Viljem Kovač, 2015, preface, editorial, afterword

Keywords: pljučni rak, izobraževanje, zborniki
Published in DiRROS: 08.05.2020; Views: 1297; Downloads: 375
.pdf Full text (133,65 KB)

9.
Ali res obstaja alternativno zdravljenje pljučnega raka
Mirjana Rajer, 2016, published professional conference contribution (invited lecture)

Keywords: rak pljuč, zdravljenje, alternativno zdravljenje
Published in DiRROS: 08.05.2020; Views: 1747; Downloads: 453
.pdf Full text (90,87 KB)

10.
Zbornik
2015, proceedings of professional or unreviewed scientific conference contributions

Published in DiRROS: 23.04.2020; Views: 1382; Downloads: 427
.pdf Full text (4,90 MB)

Search done in 0.35 sec.
Back to top